Notes
Journal of Natural Products, 2008, Vol. 71, No. 9 1659
(3H, s, 7-OCH3), 2.51 (1H, m, H-9ꢀ), 2.39 (3H, s, 8-OCOCH3), 2.10
(1H, dd, J ) 14.4, 5.6 Hz, H-9R), 1.65 (1H, m, H-11a), 1.53 (1H, m,
H-11b), 1.34 (2H, brm, H2-12), 0.88 (3H, t, J ) 7.2 Hz, H3-13); 13C
NMR (100 MHz, CDCl3) δ 168.8 (C, 8-OCOCH3), 159.5 (C, C-1),
157.5 (C, C-6), 145.5 (C, C-8), 142.6 (C, C-7), 132.2 (C, C-4a), 109.8
(C, C-8a), 109.5 (CH, C-5), 79.4 (CH, C-3), 78.4 (CH, C-10), 74.0
(CH, C-4), 60.7 (CH3, 7-OCH3), 55.8 (CH3, 6-OCH3), 38.5 (CH2, C-9),
37.6 (CH2, C-11), 20.5 (CH3, 8-OCOCH3), 18.6 (CH2, C-12), 13.5 (CH3,
C-13); HRESIMS m/z 373.1260 [M + Na]+ (calcd for C18H22O7 Na,
373.1263).
In a similar fashion, compound 2 (10 mg), acetic anhydride (0.3
mL), and DMAP (catalytic amount) in pyridine (1 mL) were allowed
to react at room temperature for 5 h, and the reaction mixture was
processed as described above for 4 to afford diacetate 5 (12.1 mg, 96%
yield): [R]20D +24.0 (c 0.1, in EtOH); 1H NMR of 5 (400 MHz, CDCl3)
δ 6.90 (1H, s, H-5), 4.98 (1H, brs, H-3), 4.92 (1H, m, H-11), 4.59
(1H, d, J ) 3.6 Hz, H-4), 4.26 (1H, m, H-10), 3.97 (3H, s, 6-OCH3),
3.84 (3H, s, 7-OCH3), 2.48 (1H, m, H-9ꢀ), 2.40 (3H, s, 11-OCOCH3),
2.21 (1H, dd, J ) 14.4, 6.0 Hz, H-9R), 2.09 (3H, s, 8-OCOCH3), 1.62
(2H, m, H2-12), 0.87 (3H, t, J ) 7.6 Hz, H3-13); 13C NMR (100 MHz,
CDCl3) δ 171.5 (C, 11-OCOCH3), 169.5 (C, 8-OCOCH3), 160.0 (C,
C-1), 158.0 (C, C-6), 146.0 (C, C-8), 143.2 (C, C-7), 132.2 (C, C-4a),
110.4 (C, C-8a), 110.0 (CH, C-5), 78.9 (CH, C-3), 78.7 (CH, C-10),
74.7 (CH, C-11), 74.4 (CH, C-4), 61.2 (CH3, 7-OCH3), 56.3 (CH3,
6-OCH3), 35.6 (CH2, C-9), 23.7 (CH2, C-12), 21.0 (CH3, 8-OCOCH3),
21.0 (CH3, 11-OCOCH3), 9.9 (CH3, C-13); HRESIMS m/z 431.1321
[M + Na]+ (calcd for C20H24O9 Na, 431.1318).
CHAGO (lung carcinoma), Hep-G2 (hepatocarcinoma), KATO-3
(gastric carcinoma), and SW-620 (colon carcinoma), using the MTT
[3-(4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide] colori-
metric method.22
Acknowledgment. Financial support from The Asahi Glass Founda-
tion, Japan, and The 90th Anniversary of Chulalongkorn University
Fund (Ratchadaphisek Somphot Endowment Fund) is gratefully
acknowledged. We also thank the National Center of Excellence for
Petroleum, Petrochemicals, and Advanced Materials, NCE-PPAM, for
partial support and Ms. S. Harntanong, Program in Biotechnology,
Faculty of Science, Chulalongkorn University, for cytotoxicity assays.
References and Notes
(1) Schulz, B.; Boyle, C.; Draeger, S.; Rommert, A.-K.; Krohn, K. Mycol.
Res. 2002, 106, 996–1004.
(2) Strobel, G. A. Microbes Infect. 2003, 5, 535–544.
(3) Wijeratne, E. M. K.; Paranagama, P. A.; Marron, M. T.; Gunatilaka,
M. K.; Arnold, A. E.; Gunatilaka, A. A. L. J. Nat. Prod. 2008, 71,
218–222.
(4) Wu, S.-H.; Chen, Y.-W.; Shao, S.-C.; Wang, L.-D.; Li, Z.-Y.; Li, S.-
L.; Huang, R. J. Nat. Prod. 2008, 71, 731–734.
(5) Ding, G.; Liu, S.; Guo, L.; Zhou, Y.; Che, Y. J. Nat. Prod. 2008, 71,
615–618.
(6) Alker, A. P.; Smith, G. W.; Kim, K. Hydrobiologia 2001, 460, 105–
111.
(7) De, R.; Purkait, R.; Pal, A. K.; Purkayastha, R. P. Indian J. Exp. Biol.
1999, 37, 706–709.
(8) Giha, O. H. Niger. J. Plant Prot. 1977, 3, 167–177.
(9) Tan, R. X.; Jensen, P. R.; Williams, P. G.; Fenical, W. J. Nat. Prod.
2004, 67, 1374–1382.
(10) Zhang, W.; Krohn, K.; Draeger, S.; Schulz, B. J. Nat. Prod. 2008,
71, 1078–1081.
(11) Aldridge, D. C.; Turner, W. B. J. Soc., Sect. C 1970, 18, 2598–2600.
(12) Robenson, D. J.; Strobel, G. A. Agric. Biol. Chem. 1982, 46, 2681–
2683.
Preparation of (R)-MTPA Ester (2a) and (S)-MTPA Ester (2b).
A reaction mixture of 2 (2 mg), (S)- or (R)-MTPA Cl (20 µL), and
DMAP (catalytic amount) in pyridine (0.25 mL) was stirred at room
temperature overnight. After removing the solvent under reduced
pressure, the (R)- and (S)-MTPA esters (2a and 2b) were purified by
mini-column chromatography on silica gel with EtOAc (1:4).
1
Compound 2a: H NMR of 2R-MTPA ester (400 MHz, CDCl3) δ
(13) Cuq, F.; Herrmann-Gorline, S.; Klabe, A.; Rossignol, M.; Petitprez,
M. Phytochemistry 1993, 34, 1265–1270.
(14) Lim, C.-H. Agric. Chem. Biotechnol. (Engl. Ed.) 1999, 42, 45–47.
(15) Grove, J. F.; Pople, M. J. Chem. Soc., Perkin Trans. 1 1979, 2048–
2051.
6.57 (1H, s, H-5), 5.25 (1H, m, H-11), 5.03, (1H, m, H-3), 4.37 (1H,
d, J ) 3.6 Hz, H-4), 4.24 (1H, m, H-10), 3.98 (3H, s, 6-OCH3), 3.91
(3H, s, 7-OCH3), 2.56 (1H, m, H-9ꢀ), 2.15 (1H, dd, J ) 14.0, 6.2 Hz,
H-9R), 2.10 (1H, m, H-12a), 1.74 (1H, m, H-12b), 1.17 (3H, t, J ) 7.2
Hz, H3-13).
(16) Claydon, N.; Grove, J. F.; Pople, M. J. InVertebr. Pathol. 1979, 33,
1
364–367.
Compound 2b: H NMR of 2S-MTPA ester (400 MHz, CDCl3) δ
(17) Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95, 512–519.
(18) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Org. Chem.
1991, 56, 1296–1298.
(19) Schulz, B.; Sucker, J.; Aust, H. J.; Krohn, K.; Ludewig, K.; Jone,
P. G.; Doring, D. Mycol. Res. 1995, 99, 1007–1015.
(20) Desjardins, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D.
Antimicrob. Agents Chemother. 1979, 16, 710–718.
(21) Trager, W.; Jensen, J. B. Science 1976, 193, 673–675.
(22) Twentyman, P. R.; Luscombe, M. A. Br. J. Cancer. 1987, 56, 279–
285.
6.58 (1H, s, H-5), 5.23 (1H, m, H-11), 4.97, (1H, m, H-3), 4.50 (1H,
d, J ) 3.2 Hz, H-4), 4.12 (1H, m, H-10), 3.96 (3H, s, 6-OCH3), 3.94
(3H, s, 7-OCH3), 2.29 (1H, m, H-9ꢀ), 2.12 (1H, m, H-12a), 2.04 (1H,
dd, J ) 14.2, 5.8 Hz, H-9R), 1.92 (1H, m, H-12b), 1.26 (3H, t, J ) 7.0
Hz, H3-13).
Biological Assays. Antimalarial activity in vitro was determined by
means of the microculture radioisotope technique based on the method
decribed by Desjardins.20 The parasite P. falciparum (K1, multidrug-
resistant strain) was cultured continuously according to the method of
Trager and Jensen.21 An IC50 value of 4.0 × 10-3 µM (n ) 3) was
observed for the positive control, dihydroartemisinin. Cytotoxicity was
assessed against human cell cultures, BT474 (breast carcinoma),
(23) Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell,
B. Cancer Res. 1987, 47, 936–942.
NP8004024